From: BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
BRCA1-related carcinomas | Grades 1–2 vs. 3 | Ductal vs. lobular tumors | ER-positive vs. ER-negative | PR-positive vs. PR-negative | HER2-positive vs. HER2-negative | |||||
---|---|---|---|---|---|---|---|---|---|---|
Probe | Test statistica | p Value | Test statistica | p Value | Test statistica | p Value | Test statistica | p Value | Test statistica | p Value |
BRCA1.1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BRCA1.2 | 0.145b | 0.653 | 1.262b | 0.356 | 0.087b | 1.000 | 0.038b | 1.000 | 0.225b | 1.000 |
BRCA1.3 | 0.031b | 1.000 | 0.342b | 1.000 | 0.115b | 1.000 | 0.096b | 1.000 | 0.151b | 1.000 |
BRCA1 totalc | 0.145b | 0.653 | 1.262b | 0.356 | 0.087b | 1.000 | 0.038b | 1.000 | 0.225b | 1.000 |
BRCA2.1 | 0.005b | 1.000 | 1.694b | 0.310 | 0.000b | 1.000 | 0.363b | 0.669 | 0.308b | 1.000 |
BRCA2.2 | 0.009b | 1.000 | 0.265b | 1.000 | 3.482b | 0.099 | 0.001b | 1.000 | 0.117b | 1.000 |
BRCA2.3 | 0.003b | 1.000 | 3.328b | 0.144 | 0.209bb | 0.740 | 0.070b | 1.000 | 0.793b | 1.000 |
BRCA2.4 | 0.975b | 1.000 | 0.193b | 1.000 | 1.625b | 0.253 | 1.121b | 0.556 | 0.086b | 1.000 |
BRCA2 totalc | 0.005b | 1.000 | 1.694b | 0.310 | 0.000b | 1.000 | 0.363b | 0.669 | 0.308b | 1.000 |